Financials
- Market Capitalization 2.06 B
- Employee 264
- Founded 2003
- CEO Kenneth Galbraith
- Website www.zymeworks.com
- Headquarter Delaware, United States
- FIGI BBG019XSYC89
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-24.38
주가매출액비율
18.74
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 1981 | VCEL Vericel Corporation - Common Stock | 41.18 USD | -2.97% | -2.79% | -11.61% | +13.29% | 2.11 B USD | ||
| 1984 | STOK Stoke Therapeutics, Inc. - Common Stock | 32.59 USD | -1.51% | +2.61% | +10.74% | +62.95% | 2.10 B USD | ||
| 2004 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 34.28 USD | +0.85% | +1.48% | -4.33% | -21.00% | 2.05 B USD | ||
| 2040 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.96 USD | -1.00% | -3.56% | +10.17% | +109.86% | 1.94 B USD |